Details of the Drug Reposition

General Information of This Drug (ID: DMP05GL)

• Drug Name: LYC-30937 (DMP05GL)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Ulcerative colitis	DIS8K27O	DD71	Phase 2	[1]
Plaque psoriasis	DISQX1LF	EA90.0	Phase 2	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)